<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03738631</url>
  </required_header>
  <id_info>
    <org_study_id>T171/2018</org_study_id>
    <nct_id>NCT03738631</nct_id>
  </id_info>
  <brief_title>Cardiac Biomarkers After Marathon Running and Coronary Atherosclerosis</brief_title>
  <acronym>MaraCat</acronym>
  <official_title>Association of Cardiac Biomarker Elevation After Marathon Running and Coronary Atherosclerosis - the MaraCat Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Turku</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates cardiac biomarkers and their association to coronary artery disease in
      marathon runners.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The MaraCat study is an observational prospective study evaluating the association between
      cardiac biomarkers and coronary artery disease in 43 runners participating in the 2018 Paavo
      Nurmi Marathon. The study participants were recruited according to two age criteria - under
      35 years and over 44 years of age. Comprehensive laboratory samples were collected
      immediately after the run, while the control workup was done in a separate visit with no
      significant physical excercise in the preceding two weeks. In the under 35 years -group, the
      control workup included an echocardiography, ecg and blood samples. In the over 44 years
      group, the control studies included coronary CT, echocardiography, ecg and laboratory tests.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 17, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac Troponin-T level after marathon</measure>
    <time_frame>0-30minutes after finishing the Paavo Nurmi Marathon</time_frame>
    <description>Cardiac troponin-T levels (ng/L), [electrochemiluminescence (ECLIA) method]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Association Cardiac troponin-T level and coronary CT findings</measure>
    <time_frame>Cardiac Troponin-T 0-30 minutes after finishing the Paavo Nurmi Marathon. Control Troponin-T levels and coronary CT angiography at control visit (&gt;30days after marathon).</time_frame>
    <description>Cardiac troponin-T levels (ng/L), [electrochemiluminescence (ECLIA) method]</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">43</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Under 35 years</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Over 44 years</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Male participants of the Paavo Nurmi Marathon 2018
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age under 35 years or over 44 years

          -  Participant of Paavo Nurmi Marathon 2018

          -  Informed consent signed

        Exclusion Criteria:

          -  No informed consent

          -  existing coronary artery disease
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Turku University Hospital, Heart Center</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>September 21, 2018</study_first_submitted>
  <study_first_submitted_qc>November 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2018</study_first_posted>
  <last_update_submitted>June 6, 2019</last_update_submitted>
  <last_update_submitted_qc>June 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Turku University Hospital</investigator_affiliation>
    <investigator_full_name>Juhani Airaksinen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

